ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE rejects Novartis’ migraine prevention drug Aimovig
January 10, 2019Some migraine sufferers in the UK hoping to get access to Novartis’ new migraine prevention drug Aimovig are facing disappointment after NICE rejected it in draft guidance. -
US OK’s first-in-class drug Aimovig for migraine prevention
May 24, 2018The monoclonal antibody offers patients a novel therapeutic approach as the first to block the calcitonin gene-related peptide receptor (CGRP-R), which is thought to play a critical role in migraine.
Pharma Sources Insight January 2025
